Lecture 9: Vaccines Flashcards

Prevention and eradication and control of infectious diseases. Goals here today are to introduce class to vaccines, their types, pros and cons, immunity, and efficacy and impacts on human health.

1
Q

Active immunity

A

Protection is make in someone as a result of exposure to antigen or pathogen (natural infection or vaccine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Passive immunity

A

Pre-formed protection provided when an individual receive antibodies from someone (breast milk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the vaccine pathway to infection?

A

Infected, disease, immunity. Vaccine bypasses the disease step

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Vaccines stimulate our immune system to make ______ without leading to _________

A

Antibodies, infection caused by the pathogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Following a vaccine, a patient faces secondary exposure to disease A. What happens?

A

A secondary response to the second exposure is faster and leads to more antibody production than we saw in the initial exposure from the vaccine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Primary response

A

7-14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anamestic response

A

1-2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Live-attenuated vaccine

A

Highly effective, contraindicated in immunocompromised and pregnant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What types of disease can LA vaccines protect patients from?

A

Mumps, measles, rubella, VZV, rotavirus, yellow fever

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Inactivated Vaccine

A

Not as immunogenic as live vaccines and usually need a few boosters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some diseases that a killed vaccine can protect patients from?

A

Hep A, Influenza

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Polysaccharide Vaccines

A

Affect the outer coating of a vaccine. Not very immunogenic and require frequent boosters.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some diseases that a poly-vaccine can protect patients from?

A

Heb B, pneumococcal 23

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some detriments to a polysaccharide vaccine?

A

Elicits few T cell immune responses in kids under 2, doesn’t alter bacterial carriage, progressive boosters might not elicit same quality of immune responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Toxoid Vaccines

A

Made of bacterial toxins that are rendered harmless to protect against activity of toxins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Subunit Vaccines

A

Immune responses to part of the pathogen.
-Protein subunits
-Good T-cell immunity and leads to reduction in organism carriage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

mRNA Based Vaccines

A

-Viral genetic code is used to develop the vaccine
-Vaccine leads to protein production which issued by T cells to destroy diseased cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Recombinant Vector Vaccines

A

Use one virus to transport proteins of another virus into pt. Strong immune responses, issues finding viral vectors that don’t have pre-existing immune responses

18
Q

What are some inDEVO DNA vector vaccines being developed?

A

WNV, HIV, measles, malaria, ebola

19
Q

What are some characters of a good viral vector?

A

Safe, low toxicity, can be cell specific, stable over time, not integrate with host DNA, immunogenic with little pre-existing immunity

20
Q

Properties of a good vaccine

A

Stable, easy to transport, long term protection, inexpensive

21
Q

Basic summary of how a vaccine works?

A

-Presents the antigen or foreign proteins to the host
-Host T-cell or antibody response (fluid form with preservatives and stabilizers so they can can be stored over time)
-Typically proteins need to be carried on immune agonists (adjuvants)

22
Q

What is an adjuvant

A

Immune agonists that can elicit strong immune response. This is things like typhoid toxin, alum

23
Q

Example of live attenuated

A

Varicella, mumps, measles

24
Q

Example of subunit vaccine

A

Bodetella pertussis

25
Q

Toxoid toxin example

A

tetanus and diphtheria

25
Q

Example of polysaccharide vaccine

A

streptococcus pneumococcus, N. meningitis

26
Q

mRNA vaccine example

A

SARS-CoV-2

26
Q

Recombinant DNA vaccine example

27
Q

Individual protection

A

Protects whoever took the vaccine

28
Q

Community protection

A

Vaccination of a large proportion of the population allows for a reduction in the chances of non immune person becoming infected as well (herd immunity)

29
Q

How much of the population must be vaccinated to achieve herd immunity?

30
Q

Vaccination may not lead to reduction in carriage this means…

A

Pathogen can still be circulating despite high levels of vaccination

31
Q

What are some things that can affect vaccine efficacy?

A

Vaccine compliance, environmental factors, persons immune status, how infectious the disease is

32
Q

Passive immunization

A

Temporary protection. Directly give them someone else’s or lab antibodies. When there is no time to wait for vaccine induced response. This is an outbreak, severe infection, PEP

Challenging to prepare since you need to ensure that the passive immunization form is free of all infectious agents

33
Q

Describe some situations where we may use passive immunity to protect patients?

A

Hep A/B, VZV, Measles, rabies, tetanus, diphtheria

34
Q

What is the most effective public health intervention?

35
Q

HPV: What is it? When does it rise?

A

STI, rise in infection rates in young, sexually active population, usually asymptomatic infection and cleared by immune system. This can progress to cervical cancer

36
Q

What is the development of cervical cancer from HPV linked to?

A

Ability to the virus to disrupt normal cell-cycle control which promotes uncontrolled cell division and accumulation of genetic damage

37
Q

Describe the basis of protection from HPV in the vaccine?

A

Neutralizing serum IgG that transudates from capillaries to genital epithelial mucosa and then bind to the viral particle

38
Q

Efficacy of HPV vaccine

39
Q

What virus causes shingles?

A

Varicella zoster from chicken pox. You don’t need to be re-infected to develop shingles

40
Q

Who is the shingles vaccine given to?

A

Anyone over the age of 50